Siemens Healthineers AG (LTS:0PMJ) Moat Score: 7/10 (As of Jul. 09, 2026)


LTS:0PMJ Siemens Healthineers AG LTS:0PMJ
79 GF Score
Price €34.43
GF Value €52.21
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Moat Score?

Siemens Healthineers AG LTS:0PMJ -2.69% 79 Moat Score is 7 as of Jul. 09, 2026. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €52.21 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 843 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 98.93% on this metric.

Siemens Healthineers AG has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Siemens Healthineers AG has Wide Moat: Siemens Healthineers AG has a wide moat due to its market leadership, strong brand, and valuable intellectual property. It benefits from significant customer switching costs and regulatory barriers in the healthcare industry, along with consistent innovation and R&D capabilities.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Siemens Healthineers AG might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Siemens Healthineers AG  (LTS:0PMJ) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Siemens Healthineers AG Moat Score Related Terms

LTS:0PMJ vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Moat Score falls into.


LTS:0PMJ
79GF Score
Siemens Healthineers AG LTS:0PMJ
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Siemens Healthineers AG (LTS:0PMJ) has a Moat Score of 7 as of Jul. 09, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Siemens Healthineers AG ranks #9 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Siemens Healthineers AG's Moat Score too high?
Siemens Healthineers AG's current Moat Score is 7. Based on the distribution chart, Siemens Healthineers AG ranks #9 out of 843 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #9 out of 843 companies for Moat Score. This places Siemens Healthineers AG in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Siemens Healthineers AG's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Possible Value Trap. The stock's GF Value™ is €52.21, compared to a current price of €34.43 — trading 34.1% below its estimated fair value. The current Moat Score is 7. Siemens Healthineers AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Moat Score is 7 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €34.43 is trading 34.1% below its estimated GF Value™ of €52.21. GuruFocus considers Siemens Healthineers AG to be Possible Value Trap.

Key valuation signals for LTS:0PMJ:

  • Moat Score: 7
  • GF Value™: €52.21 vs. price of €34.43 (34.1% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score

Get the complete analysis for LTS:0PMJ

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.43
Price
€52.21
GF Value